Age-specific dementia rates in wealthy nations have fallen roughly 13% per decade since the late 1980s. While the total number of Americans with dementia could exceed 1 million annually by 2060 due to an aging population, individual risk is dropping because of improved cardiovascular health and lifestyle factors, according to Vox reporter Bryan Walsh. Why … Read more
The Battle for Your Roof: Why Insurance “Matching” Disputes Are Escalating For most homeowners, the monthly insurance premium is a peace-of-mind purchase. We operate under the assumption that when a storm tears through the neighborhood, the insurance company will step in to restore the home to its pre-loss condition. However, a growing trend of “minimalist” … Read more
The Silent Suffering of Shingles: Why Awareness is Finally Rising For many, shingles is dismissed as a minor ailment – a painful rash that eventually fades. But a growing body of evidence, and the personal accounts of those affected, reveal a far more complex and debilitating condition. Like Ann Garner, a 73-year-old retired pharmacy administrator … Read more
Shingles Vaccine Shows Promise in Delaying Dementia: A Modern Look at the Virus-Brain Connection Emerging research suggests a surprising link between common viral infections, particularly those caused by herpesviruses, and the development of dementia. A recent study, currently available as a preprint on SSRN, indicates that vaccination against herpes zoster (shingles) and antiviral therapies may … Read more
Measles Exposure in Oregon City: A Sign of Rising Concerns? Oregon City residents are being alerted to a potential measles exposure at the Providence Willamette Falls Medical Center’s emergency department waiting room. The Oregon Health Authority (OHA) identified the period of concern as between 9:57 p.m. On Wednesday, February 25th and 12:22 a.m. On Thursday, … Read more
Here are a few options for the SEO title:
Shingles Vaccines in South Africa: A Look at What’s Missing and What’s Ahead The article you provided highlights a pressing healthcare issue in South Africa: the limited access to shingles vaccines. While the older vaccine, Zostavax, is no longer available, the newer, more effective Shingrix vaccine hasn’t yet been registered. This leaves many vulnerable individuals … Read more
The Long-Term Efficacy of Valacyclovir in Herpes Zoster Ophthalmicus Recent findings from a placebo-controlled trial suggest nuanced benefits for patients taking low-dose suppressive valacyclovir for herpes zoster ophthalmicus (HZO). This noteworthy study, led by Dr. Elisabeth J. Cohen, demonstrated significant effects at 18 months but not at the initial 12-month evaluation, highlighting the importance of … Read more
The Surprising Role of Shingles Vaccines in Dementia Prevention New research suggests an unexpected ally in the fight against dementia—a vaccine originally developed for shingles. Recent studies, including a significant one published in Nature, indicate that the shingles vaccine may reduce the risk of developing dementia by 20% over seven years. This finding is particularly … Read more
Understanding the Growing Concern of Shingles Among Older Adults A recent global survey revealed that a significant 56.6% of Indians aged 50 and above are unaware of shingles, even though most in this age bracket have the dormant virus and are at risk. This scenario is not unique to India, as the survey included responses … Read more
The Rise of CNS Infections Post-2019 The emergence of more frequent central nervous system (CNS) infections among adults, especially aseptic meningitis triggered by the varicella zoster virus (VZV), is a growing concern for healthcare professionals. Incidents have risen notably since 2019, despite the introduction of universal varicella vaccinations in Japan six years prior. This correlation … Read more